The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia

Abstract A 17‐gene stemness (LSC17) score determines risk in acute myeloid leukaemia patients treated with standard chemotherapy regimens. The present study further analysed the impact of the LSC17 score at diagnosis on outcomes following allogeneic haematopoietic cell transplantation (HCT). Out of...

Full description

Bibliographic Details
Main Authors: Dennis D. H. Kim, Igor Novitzky Basso, Taehyung Simon Kim, Seong Yoon Yi, Kyoung Ha Kim, Tracy Murphy, Steven Chan, Mark Minden, Ivan Pasic, Wilson Lam, Arjun Law, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Lipton, Rajat Kumar, Stanley W. K. Ng, Tracy Stockley, Tong Zhang, Ian King, Jonas Mattsson, Jean C. Y. Wang
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:eJHaem
Subjects:
Acute leukaemia
AML
Gene expression
LSC 17 score
Stem cell transplantation
Online Access:https://doi.org/10.1002/jha2.466

Internet

https://doi.org/10.1002/jha2.466

Similar Items